NewsEngineered helper T cells targeting MAGE-A3 produced some clinical responsesAuthor:Daniel M. KellerPublish date: April 18, 2016 Key clinical point: Engineered helper T cells safely target tumors and produce clinical responses. Major finding: Three of 14 patients with differ...Read More
NewsStudy found long-term benefit of nivolumab for advanced melanoma patientsAuthor:Daniel M. KellerPublish date: April 18, 2016 Key clinical point: Heavily pretreated patients with advanced melanoma had long-term responses on nivolumab monotherapy. Major finding: Nivolumab ...Read More
